Abstract
The contribution of mitochondrial dysfunctions to diseases such as cancer, diabetes, cardiovascular, and neurodegenerative diseases has made mitochondria an attractive pharmacological target. To deliver biologically active molecules to mitochondria, however, cellular and mitochondrial barriers must be first overcome. The mitochondrial transmembrane electric potential (negative inside) is among the most commonly used strategies to deliver molecules to mitochondria as it allows the accumulation of positively charged molecules. Thus, therapeutic molecules are either covalently conjugated to lipophilic cations like triphenylphosphonium (TPP) or loaded into nanocarriers conjugated to TPP.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Frantz MC, Wipf P (2010) Mitochondria as a target in treatment. Environ Mol Mutagen 51:462–475
Reily C, Mitchell T, Chacko BK et al (2013) Mitochondrially targeted compounds and their impact on cellular bioenergetics. Redox Biol 1:86–93
Olszewska A, Szewczyk A (2013) Mitochondria as a pharmacological target: magnum overview. IUBMB Life 65:273–281
Szewczyk A, Wojtczak L (2002) Mitochondria as a pharmacological target. Pharmacol Rev 54:101–127
Fulda S, Galluzzi L, Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447–464
Malty RH, Jessulat M, Jin K et al (2015) Mitochondrial targets for pharmacological intervention in human disease. Proteome Res 14:5–21
Wongrakpanich A, Geary SM, Joiner MA et al (2014) Mitochondria-targeting particles. Nanomed 9:2531–2543
Agrawal U, Sharma R, Vyas SP (2015) Targeted drug delivery to the mitochondria. In: Devarajan PV, Jain S (eds) Targeted drug delivery: concepts and design. Advances in delivery sciences and technology. Springer
Murphy MP (2008) Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 1777:1028–1031
Smith RAJ, Porteous CM, Gane AM et al (2003) Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci 100:5407–5412
Liberman EA, Topaly VP, Tsofina LM et al (1969) Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature 222:1076–1078
Murphy MP (2001) Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction. Expert Opin Biol Ther 1:753–764
Murphy MP, Smith RAJ (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629–656
Murphy MP (1997) Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol 15:326–330
Smith RAJ, Hartley RC, Cochemé HM et al (2012) Mitochondrial pharmacology. Trends Pharmacol Sci 3:341–352
Kelso GF, Porteous CM, Hughes G et al (2002) Prevention of mitochondrial oxidative damage using targeted antioxidants. Ann N Y Acad Sci 959:263–274
Zhang XY, Zhang PY (2016) Mitochondria targeting nano agents in cancer therapeutics. Oncol Lett 12:4887–4890
Boddapati SV, Tongcharoensirikul P, Hanson RN et al (2005) Mitochondriotropic liposomes. J Liposome Res 15:49–58
Weissig V (2003) Mitochondrial-targeted drug and DNA delivery. Crit Rev Ther Drug Carrier Syst 20:1–62
Yamada Y, Harashima H (2008) Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 60:1439–1462
Boddapati SV, D’Souza GGM, Weissig V (2010) Liposomes for drug delivery to mitochondria. Methods Mol Biol 605:295–303
Biswas S, Dodwadkar NS, Piroyan A et al (2012) Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials 33:4773–4782
Guzman-Villanueva D, Mendiola MR, Nguyen HX et al (2015) Influence of triphenylphosphonium (TPP) cation hydrophobization with phospholipids on cellular toxicity and mitochondrial selectivity. SOJ Pharma Pharm Sci 2:1–9
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Guzman-Villanueva, D., Mendiola, M.R., Nguyen, H.X., Yambao, F., Yu, N., Weissig, V. (2019). Conjugation of Triphenylphosphonium Cation to Hydrophobic Moieties to Prepare Mitochondria-Targeting Nanocarriers. In: Weissig, V., Elbayoumi, T. (eds) Pharmaceutical Nanotechnology. Methods in Molecular Biology, vol 2000. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9516-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9516-5_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9515-8
Online ISBN: 978-1-4939-9516-5
eBook Packages: Springer Protocols